Table 5.
Peri-implantitis | p | Healthy | p | |||
---|---|---|---|---|---|---|
+ | − | + | − | |||
(n = 5 subjects) | (n = 16 subjects) | |||||
(n = 8 subjects) | (n = 13 subjects) | |||||
IL-1β | 4.56 ± 12.41 | 6.33 ± 15.03 | 1.0000 | 1.91 ± 1.98 | 2.45 ± 2.64 | 0.6348 |
IL-2 | 0.05 ± 0.04 | 0.02 ± 0.02 | 0.2924 | 0.07 ± 0.08 | 0.05 ± 0.09 | 0.3980 |
IL-4 | 0.003 ± 0.005 | 0.001 ± 0,003 | 0.2796 | 0.016 ± 0.035 | 0.02 ± 0.04 | 0.6930 |
IL-6 | 0.96 ± 1.27 | 0.89 ± 1.23 | 1.0000 | 0.84 ± 0.79 | 0.40 ± 0.33 | 0.6658 |
MCP-1 | 22.11 ± 21.21 | 23.42 ± 19.18 | 0.9578 | 71.60 ± 61.38 | 105.7 ± 79.43 | 0.7414 |
MIP-1α | 4.47 ± 3.58 | 3.41 ± 3.65 | 0.4722 | 5.43 ± 4.59 | 1.42 ± 0.84 | 0.1500 |
MIP-1β | 3.48 ± 2.35 | 1.56 ± 2.22 | 0.0087 ∗ | 3.81 ± 3.07 | 2.75 ± 2.05 | 0.4865 |
TNFα | 1.28 ± 0.98 | 0.50 ± 0.45 | 0.0437 ∗ | 1.99 ± 2.05 | 0.33 ± 0.14 | 0.2256 |
∗Statistic significant.